Net Income (Quarterly) Chart

View Net Income (Quarterly) for TH.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
May 31, 2025 -6.276M
February 28, 2025 0.1675M
November 30, 2024 -10.87M
August 31, 2024 4.232M
May 31, 2024 1.345M
February 29, 2024 -6.026M
November 30, 2023 -3.762M
August 31, 2023 -0.9945M
May 31, 2023 -13.59M
February 28, 2023 -14.09M
November 30, 2022 -10.70M
August 31, 2022 -9.730M
May 31, 2022 -28.90M
February 28, 2022 -11.48M
November 30, 2021 -12.44M
August 31, 2021 -11.84M
May 31, 2021 -7.928M
February 28, 2021 -7.550M
November 30, 2020 -7.309M
August 31, 2020 -9.091M
May 31, 2020 -8.126M
February 29, 2020 -5.988M
November 30, 2019 -8.536M
August 31, 2019 -2.167M
May 31, 2019 -4.254M
Date Value
February 28, 2019 -1.635M
November 30, 2018 -1.293M
August 31, 2018 0.367M
May 31, 2018 -2.46M
February 28, 2018 -2.627M
November 30, 2017 -4.216M
August 31, 2017 -2.882M
May 31, 2017 -9.109M
February 28, 2017 -2.243M
November 30, 2016 0.173M
August 31, 2016 0.888M
May 31, 2016 -0.498M
February 29, 2016 -0.153M
November 30, 2015 0.488M
August 31, 2015 1.179M
May 31, 2015 0.818M
February 28, 2015 -0.914M
November 30, 2014 -3.62M
August 31, 2014 -4.394M
May 31, 2014 1.007M
February 28, 2014 -3.534M
November 30, 2013 -2.598M
August 31, 2013 -1.935M
May 31, 2013 -1.382M
February 28, 2013 1.86M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Spectral Medical, Inc. 0.331M
Resverlogix Corp. -8.421M
COSCIENS Biopharma, Inc. -0.2796M
Restart Life Sciences Corp. -0.3261M
Defence Therapeutics Inc -2.962M

Net Income (Quarterly) Related Metrics